Age-specific reference ranges for serum prostate-specific antigen in Korean men

Korean Journal of Urology

Volumn 47, Issue 6, 2006, Pages 586-590

  Jeon, Hyung Jin ^a   Kim, Young Sik ^b   Kang, Dae Ryeong ^a   Nam, Chung Mo ^a   Kim, Chun Il ^c   Seong, Do Hwan ^d   Kim, Se Joong ^e   Cheon, Sang Hyeon ^f   Cho, In Rae ^g   Cho, Jin Seon ^h   Hong, Sung Joon ^a   Choi, Young Deuk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Keimyung University   (South Korea)

^d Inha University   (South Korea)

^e Ajou University   (South Korea)

^f University of Ulsan   (South Korea)

^g Inje University   (South Korea)

^h Hallym University   (South Korea)

Author keywords

Age groups; Prostate specific antigen; Reference range; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CHEMOLUMINESCENCE; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; HUMAN; KOREA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; REFERENCE VALUE; STANDARDIZATION;

EID: 33748455031     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.6.586     Document Type: Article

References (22)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer. J Clin 1996;46:5-27
2. Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 1997;80:1857-63
3. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17: 159-63
4. Oesterling JE. Prostatic specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23
5. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358-68
6. Glenski WJ, Malek RS, Myrtle JF, Oesterling JE. Sustained, substantially increased concentration of prostate-specific antigen in the absence of prostatic malignant disease: an unusual clinical scenario. Mayo Clin Proc 1992;67:249-52
7. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989;142:1011-7
8. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration. An important clinical observation. Urol Clin North Am 1993; 20:671-80
9. Collins GN, Lee RJ, McKelvie AC, Rogers AC, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993;71:445-50
10. Weinrich MC, Jacobsen SJ, Weinrich SP, Moul JW, Oesterling JE, Jacobson D, et al. Reference ranges for serum prostate-specific antigen in black and white men without cancer. Urology 1998;52:967-73
11. Chung BH, Hong SJ, Lee SE, Lee DH. Serum PSA concentration, prostate specific antigen density with aging. Korean J Urol 1996;37:257-62
12. Lee TK, Chung TG, Kim CS. Age-specific reference ranges for prostate specific antigen from a health center in Korea. Korean J Urol 1999;40:583-8
13. Oesterling JE, Jacobson SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993;270:860-4
14. Dalkin BL, Abmann FR, Kopp JB. Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic cancer. J Urol 1993;150:1837-9
15. Choi YD, Hong SJ, Rha KH, Kim BH, Cha KB, Song JS, et al. Age-specific reference ranges for serum prostate-specific antigen: community-based survey in Namhae region. Korean J Urol 2001;42:834-9
16. Robles JM, Morell AR, Redorta JP, de Torres JA, Resello SA. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study. Eur Urol 1998;14:360-6
17. Cooner WH. Definition of the ideal tumor marker. Urol Clin North Am 1993;20:575-9
18. Babaian RJ, Miyashita H, Evana RB, Ramirez EI. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 1992;147:837-40
19. Benson MC, Whang IS, Pontuck A, Ring K, Kaplan SA, Olsson CA, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-6
20. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan EW, Andress R, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-20
21. Kao CH. Age-related free PSA, total PA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. Anticancer Res. 1997; 17:1361-5
22. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994; 152:1732-6